The History and Use of Human Hepatocytes for the Treatment of Liver Diseases: The First 100 Patients
Open Access
- 6 November 2014
- journal article
- unit
- Published by Wiley in Current Protocols in Toxicology
- Vol. 62 (1) , 14.12.1-14.12.23
Abstract
Orthotopic liver transplantation remains the only curative treatment for many end‐stage liver diseases, yet the number of patients receiving liver transplants remains limited by the number of organs available for transplant. There is a need for alternative therapies for liver diseases. The transplantation of isolated hepatocytes (liver cells) has been used as an experimental therapy for liver disease in a limited number of cases. Recently, the 100th case of hepatocyte transplantation was reported. This review discusses the history of the hepatocyte transplant field, the major discoveries that supported and enabled the first hepatocyte transplants, and reviews the cases and outcomes of the first 100 clinical transplants. Some of the problems that limit the application or efficacy of hepatocyte transplantation are discussed, as are possible solutions to these problems. In conclusion, hepatocyte transplants have proven effective particularly in cases of metabolic liver disease where reversal or amelioration of the characteristic symptoms of the disease is easily quantified. However, no patients have been completely corrected of a metabolic liver disease for a significant amount of time by hepatocyte transplantation alone. It is likely that future developments in new sources of cells for transplantation will be required before this cellular therapy can be fully implemented and available for large numbers of patients. © 2014 by John Wiley & Sons, Inc.Keywords
This publication has 75 references indexed in Scilit:
- Development and Application of Purified Tissue Dissociation Enzyme Mixtures for Human Hepatocyte IsolationCell Transplantation, 2012
- Chimeric Mice with Humanized Liver: Tools for the Study of Drug Metabolism, Excretion, and Toxicity2010
- Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Hepatocyte Transplantation Improves Phenotype and Extends Survival in a Murine Model of Intermediate Maple Syrup Urine DiseaseMolecular Therapy, 2009
- Hepatocyte Transplantation Followed by Auxiliary Liver Transplantation—a Novel Treatment for Ornithine Transcarbamylase DeficiencyAmerican Journal of Transplantation, 2008
- Robust expansion of human hepatocytes in Fah−/−/Rag2−/−/Il2rg−/− miceNature Biotechnology, 2007
- Hepatocyte transplantation for liver‐based metabolic disordersJournal of Inherited Metabolic Disease, 2006
- Attempts at Autologous Transplantation of Sliced Liver to the Subcutaneous TissueEuropean Surgical Research, 1983
- METABOLISM OF BILIRUBIN BY A CLONAL STRAIN OF RAT HEPATOMA CELLSJournal of Cell Biology, 1970
- Transfer of Bilirubin Uridine Diphosphate-Glucuronyltransferase to Enzyme-Deficient RatsScience, 1970